Physician profile

Ian Timothy Blahnik

Dentist · Roseville, MN

NPI 1992367809

$222.32

in general payments reported to CMS, 2019-2025

5 companies · none reported in 2025

See the full distribution for Dentist

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Education$86.07
Food and Beverage$39.39
Consulting Fee$25.00

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Align Technology, INC. $95.07 2021-2024 Invisalign, Itero
Envista Holdings Corporation $86.07 2024 Herculite Ultra Flow
3m Company $15.20 2019
Elevate Oral Care $13.40 2023 Just Right 5000, Fluorimax 5000, Advantage Arrest
Philips North America LLC $12.58 2021

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Ian Timothy Blahnik

$222.32

in general payments reported 2019-2025

Years
2019-2024
Top company
Align Technology, INC.

https://glasscript.com/doctor/6531339/ian-timothy-blahnik

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.